Skip to main content
OpenTrials
Completed

NCT Number: NCT02786654

β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure

The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Leeds

Leeds, LS2 9JT, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute myocardial infarction patients only
  • aged 18 to 100 years

Exclusion criteria

  • other final diagnosis besides acute myocardial infarction
  • died in-hospital
  • patients with missing mortality data
  • aged > 100
  • patients with previous acute myocardial infarction or angina
  • patients who have received coronary interventions before
  • patients with heart failure
  • patients with β blocker prior use
  • patients contraindicated for β blocker use
  • patients with use of a loop diuretic

Treatment and study plan

Primary outcomes

  1. All cause mortality

    Time frame: 1 year

Secondary outcomes

  1. All cause mortality

    Time frame: 6 months

  2. All cause mortality

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

University of Leeds

Other

Registry information

Important dates

Study start
2007
Primary completion
2013
Study completion
2013
First posted
Jun 1, 2016
Registry last updated
Jun 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.